NZ577915A - Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors - Google Patents

Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors

Info

Publication number
NZ577915A
NZ577915A NZ577915A NZ57791507A NZ577915A NZ 577915 A NZ577915 A NZ 577915A NZ 577915 A NZ577915 A NZ 577915A NZ 57791507 A NZ57791507 A NZ 57791507A NZ 577915 A NZ577915 A NZ 577915A
Authority
NZ
New Zealand
Prior art keywords
azabicyclo
oct
ylmethyl
phenothiazine
incontinence
Prior art date
Application number
NZ577915A
Other languages
English (en)
Inventor
Thierry Clerc
Jacky Tisne-Versailles
Christophe Przybylski
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NZ577915A publication Critical patent/NZ577915A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ577915A 2006-12-28 2007-12-26 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors NZ577915A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0656002A FR2910814B1 (fr) 2006-12-28 2006-12-28 Utilisation du 10-°(r3)-1-azabicyclo°2.2.2!oct-3-ylmethyl!-10h- phenothiazine pour la preparation d'un medicament exercant une inhibition selective des recepteurs muscariniques m1,2,3
PCT/EP2007/064553 WO2008080924A1 (fr) 2006-12-28 2007-12-26 Utilisation du 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylméthyl]-10h-phénothiazine pour la préparation d'un médicament exerçant une inhibition sélective des récepteurs muscariniques m1, m2 et m3

Publications (1)

Publication Number Publication Date
NZ577915A true NZ577915A (en) 2011-12-22

Family

ID=37951872

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ577915A NZ577915A (en) 2006-12-28 2007-12-26 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors

Country Status (21)

Country Link
US (1) US8143245B2 (enExample)
EP (1) EP2124956A1 (enExample)
JP (1) JP5564263B2 (enExample)
KR (1) KR101465277B1 (enExample)
CN (1) CN101573120B (enExample)
AR (1) AR064714A1 (enExample)
AU (1) AU2007341274B2 (enExample)
BR (1) BRPI0720591A2 (enExample)
CA (1) CA2674162A1 (enExample)
FR (2) FR2910814B1 (enExample)
IL (1) IL199557A (enExample)
MA (1) MA31026B1 (enExample)
MX (1) MX2009006950A (enExample)
NO (1) NO20092654L (enExample)
NZ (1) NZ577915A (enExample)
RU (1) RU2449794C2 (enExample)
TN (1) TN2009000257A1 (enExample)
TW (1) TWI423806B (enExample)
UA (1) UA98131C2 (enExample)
WO (1) WO2008080924A1 (enExample)
ZA (1) ZA200904304B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015133989A (ja) * 2015-04-28 2015-07-27 重泉 達志 健康食品
KR101969263B1 (ko) 2018-07-16 2019-04-15 이상호 산소 챔버용 산소 공급 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173445B (it) * 1984-03-16 1987-06-24 Guidotti & C Spa Labor Agenti ad attivita' antibroncospastica e composizioni farmaceutiche che li contengono
IT1251161B (it) * 1991-08-07 1995-05-04 Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono
AU6686700A (en) 1999-08-23 2001-03-19 H. Lundbeck A/S Treatment of urinary incontinence
AU2002366800B2 (en) * 2001-12-20 2006-08-03 Femmepharma Holding Company, Inc. Vaginal delivery of drugs

Also Published As

Publication number Publication date
US8143245B2 (en) 2012-03-27
JP2010514730A (ja) 2010-05-06
KR101465277B1 (ko) 2014-11-27
MX2009006950A (es) 2009-07-14
AR064714A1 (es) 2009-04-22
AU2007341274A1 (en) 2008-07-10
RU2009128326A (ru) 2011-02-10
JP5564263B2 (ja) 2014-07-30
RU2449794C2 (ru) 2012-05-10
FR2953721A1 (fr) 2011-06-17
AU2007341274B2 (en) 2012-09-20
HK1133207A1 (en) 2010-03-19
BRPI0720591A2 (pt) 2014-02-25
CN101573120A (zh) 2009-11-04
TWI423806B (zh) 2014-01-21
UA98131C2 (ru) 2012-04-25
KR20090103887A (ko) 2009-10-01
TN2009000257A1 (fr) 2010-10-18
WO2008080924A1 (fr) 2008-07-10
NO20092654L (no) 2009-09-28
EP2124956A1 (fr) 2009-12-02
FR2910814B1 (fr) 2011-06-17
CN101573120B (zh) 2011-11-23
TW200833331A (en) 2008-08-16
FR2910814A1 (fr) 2008-07-04
ZA200904304B (en) 2010-06-30
CA2674162A1 (fr) 2008-07-10
US20100063276A1 (en) 2010-03-11
MA31026B1 (fr) 2009-12-01
IL199557A (en) 2014-09-30

Similar Documents

Publication Publication Date Title
WO1992014453A1 (en) Compositions and methods of treatment of sympathetically maintained pain
KR20000075572A (ko) 뇨 실금, 동요병 및 어지러움을 치료하는 약물을 제조하는데있어서 데스카르보에톡시로라타딘을 이용하는 방법
CN106687115B (zh) 预防和/或治疗尿失禁的药物组合物
AU714477B2 (en) Treatment of mood/affective disorders by glutamatergic upmodulators
US20040198743A1 (en) Methods for treating allergic skin and allergic ocular conditions using combinations of histamine receptor antagonists
US8143245B2 (en) Use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic M1, M2, and M3 receptors
Sironi et al. Effects of intracavernous administration of selective antagonists of α1-adrenoceptor subtypes on erection in anesthetized rats and dogs
KR20100040294A (ko) 전립선 비대에 수반되는 하부 요로 증상의 개선용 의약 조성물
CN106243096B (zh) 三环类药物的新用途
AU2014365665B2 (en) Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
US20040248932A1 (en) Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence
US9511061B2 (en) Incontinence treatment methods
HK1133207B (en) Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors
KR20230064355A (ko) Ｎ­아세틸­ｌ­트립토판 ３，５­비스（트리플루오로메틸）벤질 에스테르 화합물을 유효성분으로 포함하는 통증의 예방 또는 치료용 약학적 조성물
Staskin Trospium chloride
BR102013021950B1 (pt) procedimento de fabricação de combinação farmacêutica contendo agente analgésico e agente antiespasmódico e combinação farmacêutica
CN106309443B (zh) 二苯甲烷类药物的用途
JP2006509783A (ja) 疼痛、片頭痛および尿失禁の処置における４−フェニル置換テトラヒドロイソキノリン類の使用

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 DEC 2015 BY ACUMASS

Effective date: 20141118

LAPS Patent lapsed